West Virginia University and GATC Health Partner to Launch Strategic Program to Accelerate Academic Research into Market-Ready Therapies
The innovative program harnesses GATC's AI-powered platform to rapidly de-risk and optimize drug discovery and development, accelerating the transition to clinical trials.
MORGANTOWN, W.Va., Jan. 28, 2025 /PRNewswire/ -- West Virginia University (WVU), one of the top public research institutions in the nation, has formed a strategic partnership with GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery. The collaborative agreement facilitates the combination of WVU's early-stage drug research and GATC's AI drug discovery platform to accelerate commercialization and create de-risked bio-tech investment opportunities.
The program aims to de-risk and accelerate the commercialization of groundbreaking research conducted at WVU. Utilizing GATC Health's Multiomics Advanced Technology™ (MAT) AI, which simulates complex systems biology with approximately 90% accuracy, the program empowers researchers to simulate billions of biological interactions, enabling rapid, accurate target discovery, drug identification, and testing at the earliest stages of drug development. By predicting safety, efficacy, and off-target effects, GATC's platform reduces the risk, time, and cost of traditional drug discovery while simulating clinical trial outcomes before laboratory work begins. GATC's technology has contributed to significant discoveries in addiction, PTSD, diabetes, obesity, glioblastoma, and cognitive decline.
The partnership not only advances academic research but also creates compelling investment opportunities by significantly reducing the risks traditionally associated with biopharma ventures. By leveraging GATC Health's AI, the program identifies high-potential projects early in the drug development process. This precision enables faster decision-making while de-risking university research as it progresses toward pre-clinical work, IND-enabling studies, and clinical trials. As the exclusive AI partner with Lloyd's of London syndicate Medical & Commercial International and in partnership with Acrisure Re Corporate Advisory & Solutions, the international financing and consulting firm responsible for program sales and distribution, GATC is supporting the underwriting of the first insurance-backed financial program to fund clinical trials, offering a secure and innovative funding source for joint ventures stemming from WVU and GATC collaborations.
"This partnership highlights West Virginia University's dedication to driving innovation and transforming lives through groundbreaking research," said Dr. Clay Marsh, Chancellor & Executive Dean for Health Sciences at West Virginia University. "By joining forces with GATC Health and utilizing their cutting-edge AI technology, we are empowering our researchers to accelerate the path from academic discovery to life-changing therapies, ensuring WVU remains at the forefront of addressing critical healthcare challenges and delivering meaningful outcomes that benefit patients in West Virginia and across the globe."
Traditional drug discovery and development is a notoriously risky, expensive, and time-consuming process, often requiring over a decade and billions of dollars to bring a single therapy to market. The high failure rate—nearly 90% of drug candidates fail during clinical trials—stems from challenges such as inaccurate target identification, unforeseen toxicity, poor efficacy, and lengthy preclinical and clinical trial processes. By applying GATC Health's AI across these critical stages, drug discovery is becoming faster, more efficient, and more likely to succeed.
"We are thrilled to partner with WVU and launch our University Research Accelerator Program," said Tyrone Lam, Chief Business Officer of GATC Health Corp. "This collaboration highlights our commitment to empowering academic institutions with cutting-edge AI tools that bridge the gap between research and commercialization, enabling faster delivery of life-changing therapies."
By focusing on high-probability projects and leveraging GATC's "fast-fail" AI analysis, WVU will not only enhance its research capacity but also generate revenue much earlier in the discovery process. This innovative approach establishes WVU as a leader in AI-driven research commercialization.
GATC West Virginia, a subsidiary of GATC Health, is enhancing its AI-powered lab operations within the WVU Innovation Building, strategically located near West Virginia University's campus. The state-of-the-art lab facilitates rapid iteration between GATC's MAT AI and traditional lab experiments. Currently, it is focused on synthesizing drug compounds, a critical step in advancing preclinical testing for innovative treatments targeting conditions such as opioid use disorder, polysubstance use disorder, post-traumatic stress disorder, anxiety, diabetes, glioblastoma, Alzheimer's and more. To support this growth, GATC West Virginia is expanding its preclinical capabilities by hiring additional scientists this year, reinforcing its commitment to innovation and scientific excellence.
About West Virginia UniversityWest Virginia University, located in Morgantown, WV, is a leading public research institution dedicated to creating solutions that address the challenges of today and tomorrow. Through its world-class faculty and innovative research initiatives, WVU is driving advancements across a wide range of disciplines.
About GATC Health CorpGATC Health Corp is a technology company revolutionizing drug discovery and development through its transformative AI platform and approach. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry's billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and de-risk drug pipelines by predicting efficacy, safety, and off-target effects. For more information, visit www.gatchealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-virginia-university-and-gatc-health-partner-to-launch-strategic-program-to-accelerate-academic-research-into-market-ready-therapies-302362523.html
SOURCE GATC Health Corp
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
iQor CXBPO™ Unveils infinityAiQ™ Platform Powering the Future of Intelligent Customer Experiences
Unified Intelligence Platform Integrates AI, Analytics, and Expertise to Drive Business Performance FT. LAUDERDALE, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- iQor CXBPO™, an award-winning customer experience business process outsourcing (BPO) provider, today announced the launch of infinityAiQ™, a unified intelligence platform that combines human expertise, AI, and analytics to optimize every stage of the customer experience. The platform is designed to help clients deepen loyalty, reduce costs, and increase revenue through smarter, more adaptive CX operations. Built to power iQor's CXBPO model, the infinityAiQ platform integrates intelligence across the agent and customer lifecycles — from hiring and training to engagement, resolution, and recovery. It combines secure infrastructure, proprietary AI tools, and enriched data pipelines into a cohesive, scalable system. A key component, Insights iQ™, extracts predictive, real-time intelligence from every customer interaction. Powered by iQor's VALDI advanced analytics engine and enhanced through an industry-first collaboration with OpenAI, Insights iQ enables brands to act on 100% of conversations — not just samples — to uncover trends, detect churn risks, and accelerate action. 'infinityAiQ is the engine propelling our CXBPO model to help clients compete in a world where customer experience drives business growth,' said iQor President and CEO Chris Crowley. 'By harnessing data, technology, and expertise, we deliver a scalable foundation for faster innovation, smarter decisions, and stronger customer relationships. This platform enables our clients to move beyond traditional outsourcing models and into proactive, insight-driven growth.' infinityAiQ offers three integrated solution pillars to help brands turn customer experience into competitive advantage: People iQ: Intelligent hiring, onboarding, and training systems that match best-fit talent to client needs, building high-performing, scalable teams. Process iQ: Streamlined workflows and automation that reduce costs and improve speed, accuracy, and customer satisfaction. Insights iQ: Predictive analytics and real-time decisioning tools that identify patterns, uncover opportunities, and drive revenue-enhancing CX strategies. iQor's investment in automation and machine learning enables its infinityAiQ platform to process over 2.7 billion tokens per week through LLMs and apply advanced predictive analytics to 100% of the call volume, driving significant improvements in performance and customer experience. 'infinityAiQ is the culmination of years of investment in secure infrastructure, proprietary AI, and advanced analytics,' said Prabhjot Singh, Chief Digital Officer at iQor. 'We've engineered a platform that transforms unstructured data from every interaction into real-time business intelligence — fueling predictive decisioning, automation, and continuous optimization across the CX journey.' With iQor's PCI-DSS, SOC 1 and 2 Type 2, HITRUST, and ISO 27001 certifications, as well as HIPAA compliance, infinityAiQ provides clients with the confidence of operating on a secure, resilient infrastructure. Whether deployed as a full contact center solution or integrated with existing systems, the platform is designed to deliver unmatched intelligence and flexibility across omnichannel environments without disruption. To learn more about how infinityAiQ powers unified intelligence for unmatched CX results, visit About iQor CXBPO™iQor CXBPO™ is a trusted partner in intelligent customer experience solutions, delivering exceptional results for global brands. With 40,000 employees across 10 countries, we combine 30 years of industry expertise with cutting-edge AI-driven innovations to optimize customer interactions at every stage. Our agile, scalable solutions ensure seamless omnichannel engagement, driving loyalty and measurable business success. Recognized as a Great Place to Work® and a leader in CX excellence, we elevate performance through a people-first approach, operational expertise, and secure, technology-enabled solutions. Learn more at CONTACT: iQor Global Contact Nicole Gobbo Director of Communications
Business Wire
an hour ago
- Business Wire
Writer Named a Gartner® Cool Vendor for AI Agent Development
SAN FRANCISCO--(BUSINESS WIRE)-- Writer, the leader in enterprise generative AI, today announced that it has been named a Cool Vendor in the inaugural 2025 Gartner® Cool Vendors™report for AI Agent Development. Over the last 5 years, Writer has pioneered the enterprise AI category with the world's only enterprise-focused AI research lab and now leads the industry with an end-to-end approach to agentic AI. Today, Writer's platform enables IT and business teams from hundreds of leading enterprises to collaboratively build and scale AI agents that streamline workflows across departments. According to Gartner, 'by 2029, over 60% of enterprises will adopt AI agent development platforms to automate complex workflows previously requiring human coordination.' The report states, 'Demand for AI agent development is increasing as organizations seek hyperefficiency. Software engineering leaders will find the vendors in this report valuable for addressing the growing demand from business and technology stakeholders to develop agents that will help them deliver business value faster.' Based on Writer's understanding, Cool Vendors were selected for their ability to provide both the foundational tools to harness the potential of AI agents, as well as innovative value-add functionality. Writer's primary takeaway from the report is that enterprises must invest in vendors that can offer scalability, interoperability, and stability, in addition to performance and security, to maximize long term value. 'Being named a Gartner Cool Vendor in AI Agent Development is an important recognition of Writer's platform,' said May Habib, CEO and Co-Founder of Writer. 'In a noisy market full of overpromises, Writer delivers what enterprises actually need: agentic systems that are accurate, governed, and built to scale. Our platform gives IT and business teams one place to build, activate, and supervise AI agents — grounded in business context, powered by our enterprise-grade LLMs, and built for real ROI.' Writer has recently released new product and tech innovations, including: Palmyra X5: Writer's latest foundation model, topping benchmarks for speed, cost efficiency, and large context performance. AI HQ: Writer's centralized hub to build, activate, and supervise AI agents across the enterprise. Includes a library of 100+ ready-to-use AI agents across industries including finance, healthcare, retail, and technology. Together, Palmyra X5 and AI HQ give enterprises unmatched power to deploy real-world AI agents that support use cases like market intelligence, financial reporting, legal analysis, medical record synthesis, and customer experience optimization. Hundreds of leading enterprises – including Intuit, Kenvue, Marriott, Qualcomm, Uber, Vanguard, and more – use Writer to reinvent business processes with AI at the center. Readers can access a complimentary copy of the report here. Disclaimer Gartner, Cool Vendors for AI Agent Development, Adrian Leow, Jim Scheibmeir, Nitish Tyagi, Manjunath Bhat, 27 May 2025 GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Writer Writer is where the world's leading enterprises orchestrate AI-powered work. With Writer's end-to-end platform, teams can build, activate, and supervise AI agents that are grounded in their company's data and fueled by Writer's enterprise-grade LLMs. From faster product launches to deeper financial research to better clinical trials, companies are quickly transforming their most important business processes for the AI era in partnership with Writer. Founded in 2020, Writer delivers unmatched ROI for hundreds of customers like Accenture, Intuit, Marriott, Uber, and Vanguard and is backed by investors including Premji Invest, Radical Ventures, ICONIQ Growth, Insight Partners, Balderton, B Capital, Salesforce Ventures, Adobe Ventures, Citi Ventures, IBM Ventures, and others. Learn more at
Business Wire
an hour ago
- Business Wire
Ventura Foods® Brings Innovation to Foodservice Mayonnaise
BREA, Calif.--(BUSINESS WIRE)--Today Ventura Foods®, the trusted foodservice partner for culinary professionals, introduced its new MayoNeeds™ Framework. This innovative approach eliminates confusion within the mayonnaise category by aligning specific mayonnaise formulations with specific culinary applications to meet the distinct needs of chefs and operators. 'We confirmed that not all 'Heavy Duty' mayos are the same and that chefs can often improve the quality of a dish by choosing a mayonnaise formulated for a specific application,' says David Kamen of The Culinary Institute of America. A New Way to Look at Mayonnaise Mayonnaise is a staple in commercial kitchens, appearing on nearly half of restaurant menus. Yet many operators, under pressure to manage back-of-house expenses and customer satisfaction, don't have time to really consider this critical ingredient when placing weekly orders. Additionally, the mayonnaise category lacks standard labeling definitions and uses marketing terms like 'Heavy Duty,' 'Premium,' and 'Extra Heavy,' causing added confusion. As a result, chefs and operators often default to using the same foodservice-grade mayonnaise for all their hot and cold applications, assuming it will perform consistently and unknowingly sacrificing product quality in the process. Ventura Foods is solving this problem with its new MayoNeeds™ Framework, which is designed to create clarity in the category. With its deep expertise in culinary solutions, Ventura Foods developed a new way to look at mayonnaise, not by ingredients and formulations, but by culinary applications. 'Even though this ubiquitous ingredient is integral to recipes across cuisines and menus, most chefs and operators reorder the same mayo regularly without much consideration. We want them to understand that the current labels, like Heavy Duty, are actually meaningless and consider how a mayonnaise developed for specific uses can elevate a signature dish without increasing costs,' says Ahmad Popal, Senior Vice President, Food Innovation & Customer Experience at Ventura Foods. To ensure the MayoNeeds™ Framework accurately reflects real-world kitchen needs, Ventura Foods collaborated with The Culinary Institute of America (CIA) to conduct a blind study evaluating the performance of various foodservice mayonnaise products labeled as 'Heavy Duty.' The findings revealed inconsistencies in how these products performed across mixed, bound and dippable applications, underscoring the need for clarity in the mayonnaise category. 'We confirmed that not all 'Heavy Duty' mayos are the same and that chefs can often improve the quality of a dish by choosing a mayonnaise formulated for a specific application, rather than relying on a one-size-fits-all mayonnaise,' says David Kamen, Director - Client Engagement, Consulting at The Culinary Institute of America. 'The lack of standards in mayo labeling creates confusion for chefs who rely on an essential ingredient that can make or break texture, taste, and the overall impression of the dish.' Ventura Foods is rolling out the MayoNeeds™ Framework through partnerships with foodservice leaders in various channels and encouraging them to enhance and streamline their existing mayonnaise portfolios through application-based formulations and labeling as well as education. Chefs and operators can learn more by visiting About Ventura Foods Ventura Foods is a leading producer of exclusive products, ready-to-go solutions, and consumer brands in the dressings, sauces, mayonnaises, shortenings, and oils categories. Its customers include foodservice companies, restaurants, and retailers in over 70 countries. A privately held joint venture of CHS, Inc. and Mitsui & Co., Ventura Foods manufactures products in the US, Canada, Mexico, and the Philippines. For more information, visit
